14-day Premium Trial Subscription Sign Up For FreeGet Free

No Pain, No Gain.Week 21 On Stock Market Click to watch.

Cellectis S.A. Stock Forecast

NASDAQ:CLLS BUY SELL

$3.69 (-2.38%)

Volume: 37.823k

Closed: May 23, 2022

Hollow Logo Score: -0.854

Cellectis S.A. Stock Forecast

BUY SELL NASDAQ:CLLS
$3.69 (-2.38%)

Volume: 37.823k

Closed: May 23, 2022

Score Hollow Logo -0.854

Cellectis S.A. Stock Forecast NASDAQ:CLLS

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-05-18 - Baird - Upgrades Neutral Outperform
2022-05-13 89.7% Barclays $9.00 $7.00 Maintains Overweight
2022-01-06 333.6% Wells Fargo $16.00 Downgrades Overweight Equal-Weight
2021-11-30 442.01% JMP Securities $20.00 Initiates Coverage On Market Outperform
2021-10-08 171% Baird $39.00 $10.00 Downgrades Outperform Neutral
2021-04-28 - Guggenheim - Downgrades Buy Neutral
2021-03-16 956.91% Baird $23.00 $39.00 Upgrades Neutral Outperform
2020-10-15 - Baird - Downgrades Outperform Neutral
2020-08-19 767.21% Citigroup $15.00 $32.00 Upgrades Neutral Buy
2020-07-07 469.11% Baird $28.00 $21.00 Maintains Outperform
2020-03-06 198.1% Goldman Sachs $15.00 $11.00 Downgrades Neutral Sell
2020-02-19 956.91% BTIG $37.00 $39.00 Maintains Buy
2019-08-09 - BTIG - Initiates Coverage On Buy
2019-05-24 - Citigroup - Assumes Neutral

CLLS Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -18.28% during the next 3 months and, with a 90% probability hold a price between $2.11 and $3.58 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-25 $2.57 $3.47 $4.37
2022-05-26 $2.55 $3.45 $4.35
2022-05-27 $2.53 $3.43 $4.34
2022-05-31 $2.52 $3.42 $4.32
2022-06-01 $2.50 $3.40 $4.30
2022-06-02 $2.49 $3.39 $4.29
2022-06-03 $2.47 $3.37 $4.27
2022-06-06 $2.45 $3.35 $4.25
2022-06-07 $2.44 $3.34 $4.24
2022-06-08 $2.42 $3.32 $4.22
2022-06-09 $2.41 $3.31 $4.21
2022-06-10 $2.39 $3.29 $4.19
2022-06-13 $2.37 $3.27 $4.17
2022-06-14 $2.36 $3.26 $4.16
2022-06-15 $2.34 $3.24 $4.14
2022-06-16 $2.32 $3.23 $4.13
2022-06-17 $2.31 $3.21 $4.11
2022-06-21 $2.29 $3.19 $4.09
2022-06-22 $2.28 $3.18 $4.08
2022-06-23 $2.26 $3.16 $4.06
2022-06-24 $2.24 $3.15 $4.05
2022-06-27 $2.23 $3.13 $4.03
2022-06-28 $2.21 $3.11 $4.01
2022-06-29 $2.20 $3.10 $4.00
2022-06-30 $2.18 $3.08 $3.98
2022-07-01 $2.16 $3.06 $3.97
2022-07-05 $2.15 $3.05 $3.95
2022-07-06 $2.13 $3.03 $3.93
2022-07-07 $2.12 $3.02 $3.92
2022-07-08 $2.10 $3.00 $3.90

About Cellectis S.A.

Cellectis SA Cellectis S.A., a gene-editing company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. Its lead product candidate is UCART19, an allogeneic T-cell product candidate for the treatment of CD19 expressing hematologic malignancies which develop in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia. The company’s products also include UCART1... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT